Medicines Co. Sues Mylan Over Generic Angiomax
The Medicines Co. filed a patent infringement suit against Mylan Inc. in an Illinois federal court Wednesday in an effort to block the defendant's planned generic version of its anti-coagulant drug...To view the full article, register now.
Already a subscriber? Click here to view full article